Open AccessTwo rare cases of bronchus‐associated lymphoid tissue lymphoma successfully treated with rituximab‐bendamustine
Author(s) -
Panitz Nydia,
Gerhardt Kristin,
Becker Cornelia,
Schleife Hendrikje,
Bach Enrica,
Opitz Sabine,
Schaudinn Alexander,
Platzbecker Uwe,
Kayser Sabine
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4557
Subject(s) - medicine , bendamustine , rituximab , lymphoma , bronchus , gastroenterology , oncology , pathology , lung , respiratory disease
BALT lymphoma is a rare B‐NHL with a favorable prognosis. We here report on two patients with nonspecific symptoms: one showed as major symptom severe thrombocytopenia and the other dyspnea and dry cough, thereby suggesting an inflammatory focus in the lungs. There is no standard of care established yet. Both patients were successfully treated with rituximab and bendamustine. Thus, combined immunochemotherapy should be considered as first‐line therapy as in other MALT lymphomas, if the treatment/eradication of an underlying chronic inflammatory disorder/trigger factor can be excluded.